Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Icu Medical (ICUI) Raw Materials (2017 - 2025)

Historic Raw Materials for Icu Medical (ICUI) over the last 12 years, with Q1 2025 value amounting to $29.8 million.

  • Icu Medical's Raw Materials fell 3708.79% to $29.8 million in Q1 2025 from the same period last year, while for Mar 2025 it was $29.8 million, marking a year-over-year decrease of 3708.79%. This contributed to the annual value of $28.6 million for FY2024, which is 3842.05% down from last year.
  • Per Icu Medical's latest filing, its Raw Materials stood at $29.8 million for Q1 2025, which was down 3708.79% from $28.6 million recorded in Q4 2024.
  • In the past 5 years, Icu Medical's Raw Materials registered a high of $50.3 million during Q3 2024, and its lowest value of $26.5 million during Q3 2021.
  • Its 5-year average for Raw Materials is $38.3 million, with a median of $38.5 million in 2022.
  • In the last 5 years, Icu Medical's Raw Materials skyrocketed by 3945.86% in 2022 and then plummeted by 3842.05% in 2024.
  • Quarter analysis of 5 years shows Icu Medical's Raw Materials stood at $28.5 million in 2021, then surged by 34.9% to $38.5 million in 2022, then rose by 20.78% to $46.5 million in 2023, then crashed by 38.42% to $28.6 million in 2024, then grew by 4.17% to $29.8 million in 2025.
  • Its last three reported values are $29.8 million in Q1 2025, $28.6 million for Q4 2024, and $50.3 million during Q3 2024.